Version July 2025
| Name | Manufacturer | Stent material | Drug | Polymer (thickness) and drug-elution kinetics |
| Durable polymer drug-eluting stents currently in use | ||||
| Xience (Sierra, V, Prime, Xpedition) | Abbott Vascular | Cobalt chromium | Everolimus | PBMA/PVDF-HFP 7.6 micrometers; 80% within four weeks |
| Promus (Elite, Premier) | Boston Scientific | Platinum chromium | Everolimus | PBMA/PVDF-HFP 7.6 micrometers; 80% within four weeks |
| Resolute (Onyx, Integrity) | Medtronic | Cobalt chromium | Zotarolimus | Biolynx* 5.6 micrometers; 85% within eight weeks |
| Elunir | Medinol | Cobalt chromium | Ridaforolimus | CarboSil 20 55D and PBMA 7 micrometers thick; 100% within 180 days |
| Bioabsorbable polymer drug-eluting stents currently in use | ||||
| SYNERGY | Boston Scientific | Platinum chromium | Everolimus | Poly-lactide-co-glycide¶ 4 micrometers; >95% within 90 days |
| Orsiro | Biotronik | Cobalt chromium | Sirolimus | BIOlut poly-L-lactideΔ 7.5 micrometers; >95% within 14 weeks |
| Previously approved drug-eluting stents (no longer in clinical use) | ||||
| Cypher | Cordis/J&J | Stainless steel | Sirolimus | PEVA/PBMA 12.6 micrometers; >80% within four weeks |
| Taxus | Boston Scientific | Stainless steel | Paclitaxel | SIBBS 16 micrometers; approximately 10% over two weeks |
| Taxus Ion | Boston Scientific | Platinum chromium | Paclitaxel | SIBBS 16 micrometers; approximately 10% over two weeks |
| Endeavor | Medtronic | Cobalt chromium | Zotarolimus | Phosphoryl choline 5.3 micrometers; 95% within two weeks |
PBMA: poly(n-butyl methacrylate); PVDF-HFP: poly(vinylidene fluoride-hexafluoropropylene); PEVA: polyethylene-co-vinyl acetate; SIBBS: styrene-b-isobutylene-b-styrene).
* Proprietary polymer.
¶ Biodegradable polymer (absorption time 120 days).
Δ Biodegradable polymer (absorption time 12 to 24 months).
